Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 698

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 28,
Hindmarsh,
South Australia 5007

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 277KB)
Why become a member?

More positive results: Low-dose naltrexone for Fibromyalgia

Sunday 10 February 2013

 

From About.com's Adrienne Dellwo:

 

NaltrexoneMore Positive Results: Low-Dose Naltrexone for Fibromyalgia

By , About.com Guide
February 8, 2013

Stanford University researchers have again found that low-dose naltrexone (LDN) is a beneficial treatment for fibromyalgia.

The new study, just published in Arthritis and Rheumatism, aimed to confirm and expand Stanford's earlier research on LDN. It's small and still considered preliminary, but continued positive outcomes of this kind are necessary for moving up to larger studies.

In this study, participants taking LDN had:

  • 28% reduction in pain
  • Improved satisfaction with life
  • Improved mood
  • NO improvement in fatigue or sleep
  • NO serious side effects

Especially good news for people with fibromyalgia, who are often especially prone to side effects, is that LDN was tolerated just as well as a placebo.

LDN is an inexpensive, widely available medication with a long record of being safe and well tolerated. If positive results continue through larger trials, it could become an excellent option for people with fibromyalgia. As is, some doctors are willing to prescribe it, but many are likely to be reluctant until we have more data.

Have you tried LDN? How did it work? Has your doctor denied a request for it? Leave your comments here!

NEWSLETTER | FORUM | BIO | TWITTER | FACEBOOK

 

The above, with comments, originally appeared here.

 


Arrow right

More Fibromyalgia News

 


 

blog comments powered by Disqus
Previous Previous Page